# SEG Drug HTML Source Closure Decision

**Review mode:** `CONTROLLED GOVERNANCE ONLY` / read-only evidence closure  
**Target:** Drug HTML Artifact  
**Prior state:** `BLOCKED_PENDING_EVIDENCE`  
**Prepared by:** **Manus AI**

> **Decision summary:** The local HTML artifact is available and hash-consistent, with observable embedded medication-related structures and title signals. The evidence set does not close canonical identity, source lineage, rights, clinical review, or track governance. The artifact remains blocked and may be preserved only for controlled internal evidence review.

## 1. Evidence Basis and Boundary

This decision is based on the recovered artifact record for `/home/ubuntu/upload/deepseek_html_20260615_a3266b.html` and the existing SEG source-governance records. The file was fingerprinted and statically inspected only. It was not rewritten, normalized, imported, executed as a validated drug database, or exposed to learners. [1] [2]

| Evidence item | Observed evidence | Closure meaning |
|---|---|---|
| Artifact type | HTML with embedded JavaScript data arrays and Arabic/English clinical labels | Structural evidence only |
| File size | 25,918 bytes | Artifact fingerprint evidence |
| Logical lines | 395 | Artifact fingerprint evidence |
| SHA-256 | `5367711d08df2393cf852815b1b9d0ad4dac8240ac061cd88c71a53884e938ac` | Confirmed and matches the registered value |
| Observed structures | 19 `summaryData` sections, 21 `quick` entries, 47 `drugList` entities, 20 `trapsList` entries | Structural inventory only |
| Interaction table | No explicit pairwise interaction table observed | Does not prove absence of interactions elsewhere or clinical completeness |
| Title signals | Rosen/Tintinalli reference signals appear in the artifact | Does not establish canonical edition, publisher, ownership, or rights |

## 2. Source Identity Closure

| Identity requirement | Status | Evidence and unresolved point |
|---|---|---|
| Original title | `PARTIALLY_CONFIRMED` | The artifact contains Rosen/Tintinalli title signals, but no canonical source title is supplied. |
| Original publisher/owner | `NOT_AVAILABLE` | No attributable publisher, owner, or authorized custodian is evidenced. |
| Authoring organization/author | `NOT_AVAILABLE` | No author or authoring organization is evidenced. |
| Version/edition | `NOT_AVAILABLE` | No source edition, release, or immutable version is supplied. |
| Publication date | `NOT_AVAILABLE` | No publication or release date is supplied. |
| Original source location | `NOT_AVAILABLE` | The local intake path is known, but the authoritative original locator is not evidenced. |
| **Identity gate** | **`BLOCKED`** | Title signals and a local path do not close canonical identity or version lineage. |

## 3. Provenance Closure

| Provenance requirement | Status | Evidence and unresolved point |
|---|---|---|
| Artifact origin | `CONFIRMED` | The registered local HTML path and artifact fingerprint are recorded. |
| Transformation history | `NOT_AVAILABLE` | No attributable event describing extraction, conversion, translation, or rewrite is supplied. |
| Extraction lineage | `PARTIALLY_CONFIRMED` | The recovery record preserves the local representation and hash, but not the complete original-source-to-extraction event. |
| Source locators | `NOT_AVAILABLE` | No authoritative page, chapter, section, or stable source locator is supplied. |
| Chain of custody | `PARTIALLY_CONFIRMED` | Local recovery custody is documented; owner-to-original-to-extraction-to-registry continuity remains incomplete. |
| **Provenance gate** | **`BLOCKED`** | Artifact hash continuity is insufficient for complete source lineage. |

## 4. Rights and License Closure

| Rights requirement | Status | Evidence and unresolved point |
|---|---|---|
| Copyright owner | `NOT_AVAILABLE` | No ownership statement is supplied. |
| Code/HTML license | `NOT_AVAILABLE` | No license or permission statement is supplied. |
| Educational-use permission | `NOT_AVAILABLE` | No source-specific educational-use terms are evidenced. |
| Display and hosted-use permission | `NOT_AVAILABLE` | No permission for SEG display or hosted use is evidenced. |
| Redistribution and publication permission | `NOT_AVAILABLE` | No redistribution, attribution, or publication scope is evidenced. |
| Image/table/embedded asset rights | `NOT_AVAILABLE` | No asset-level rights assessment is supplied. |
| **Rights gate** | **`BLOCKED_PENDING_EVIDENCE`** | Rights are not inferred from possession, educational purpose, or embedded reference signals. |

## 5. Medical Review Gate

The artifact contains medication-related structures and precaution text. The recovery record expressly treats these as unvalidated text signals, not dose, interaction, or clinical-correctness findings. [1]

| Required review element | Status | Required scope |
|---|---|---|
| Emergency Medicine medication/pharmacology reviewer | `NOT_STARTED` | Review the exact retained HTML representation, medication claims, precautions, completeness claims, and intended educational scope. |
| Dose and concentration review | `NOT_STARTED` | Verify every dose, unit, concentration, threshold, and safety statement against authoritative sources. |
| Interaction and contraindication review | `NOT_STARTED` | Review any preserved interaction, contraindication, or precaution claims; no interaction table is assumed. |
| Conflict and approval record | `NOT_STARTED` | Record attributable reviewer identity/role, cited locations, conflicts, resolution, date, and explicit decision. |
| **Medical review gate** | **`BLOCKED`** | No qualified clinical-review decision is supplied. |

**Observed review state:** `PENDING_CLINICAL_REVIEW`. This report defines the required review; it does not perform or approve it.

## 6. Technical Review and Accessibility

A technical/software review is **not applicable as a source-level approval gate** for the static HTML artifact because no application integration or server behavior is being approved here. This does not authorize rendering or deployment. If the artifact is later proposed for a SEG user-facing surface, a separate technical and accessibility review must assess safe rendering, source-preserving presentation, keyboard and screen-reader behavior, contrast, responsive layout, language handling, and non-color dependence. Those reviews have not started.

## 7. SEG Destination Decision

| Decision option | Result |
|---|---|
| `READY_FOR_NORMALIZATION` | `NO` |
| `EXTERNAL_EVIDENCE_REQUIRED` | `YES` — identity, provenance, rights, medical review, and explicit track evidence remain open |
| `INTERNAL_REFERENCE_ONLY` | `YES` — controlled preservation and evidence inspection only |
| `BLOCKED_PENDING_EVIDENCE` | `YES` — current promotion gate |

**Final SEG destination:** `BLOCKED_PENDING_EVIDENCE`  
**Operational disposition:** `INTERNAL_REFERENCE_ONLY` / `WAITING_FOR_EVIDENCE`  
**The artifact must not be treated as a validated drug, dose, or interaction database.**

## 8. Exact Next Allowed Action

Obtain an owner, publisher, or authorized-custodian statement linking the local HTML to its exact source; collect source-specific rights terms; prepare a role-based Emergency Medicine medication/pharmacology review request; document the original-to-extraction-to-recovery-to-registry chain; preserve the HTML unchanged; and retain the separate audit evidence required for any later governance decision. [1]

After those evidence items are independently supplied, conduct the source-level identity, rights, provenance, and clinical review decision. No normalization, mapping, content-record creation, import, activation, publication, or learner exposure follows automatically.

## 9. Confirmed Non-Actions

```json
{
  "source_modified": false,
  "medical_content_corrected_or_rewritten": false,
  "drug_database_validated": false,
  "interaction_database_validated": false,
  "content_normalized": false,
  "content_records_created": false,
  "schemas_or_mappings_created": false,
  "sql_or_migration_executed": false,
  "database_or_supabase_changed": false,
  "content_imported": false,
  "content_activated": false,
  "content_published": false,
  "learner_exposure_enabled": false,
  "clinical_approval_granted": false,
  "rights_approval_granted": false,
  "git_operation_executed": false
}
```

## 10. Final Status

```text
SEG_DRUG_HTML_SOURCE_CLOSURE_COMPLETE
FINAL_DECISION = EXTERNAL_EVIDENCE_REQUIRED
CURRENT_GATE = BLOCKED_PENDING_EVIDENCE
OPERATIONAL_DISPOSITION = INTERNAL_REFERENCE_ONLY
READY_FOR_NORMALIZATION = NO
```

## References

[1]: file:///home/ubuntu/seg-internship-output/SEG_DRUG_HTML_RECOVERY_STATUS.md "SEG Drug HTML Recovery Status"

[2]: file:///home/ubuntu/seg-internship-output/SEG_DRUG_HTML_SOURCE_REVIEW.md "SEG Drug HTML Source Review"

[3]: file:///home/ubuntu/seg-internship-output/SEG_TARGETED_EVIDENCE_CLOSURE_PLAN.md "SEG Targeted Evidence Closure Plan"

[4]: file:///home/ubuntu/seg-internship-output/SEG_MASTER_SOURCE_REGISTRY_STATUS.md "SEG Master Source Registry Status"

---

**SEG_DRUG_HTML_SOURCE_CLOSURE_COMPLETE**
